LONDON, ONTARIO--(Marketwired - Sept. 21, 2015) - Sernova Corp. (TSX VENTURE:SVA)(FRANKFURT:PSH)(OTCQB:SEOVF), a leading clinical stage, regenerative medicine company developing biologically compatible, implantable medical device and therapeutic cellular technologies is pleased to announce it has been listed for trading on the OTCQB market exchange in the United States under the symbol "SEOVF".

"Admission to the OTCQB expands Sernova's presence in the United States, will provide our existing U.S. shareholders with an improved trading platform, and is part of our long-term strategy to introduce the company to a broader range of institutional and retail investors," stated Dr. Philip Toleikis, President and CEO of Sernova. "This is a timely move given the Company's growing international presence with its expanding corporate and academic collaborations, product development programs and partnering discussions."

The Company will be embarking on a comprehensive investor relations effort attending institutional conferences and targeted investor meetings in Toronto, Atlanta, Boston and New York.

About Sernova

Sernova Corp is a clinical stage regenerative medicine company developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including hemophilia and other diseases treated through replacement of proteins or hormones missing or in short supply within the body. Sernova is developing the Cell Pouch™, an implantable medical device for therapeutic cells (donor, xenogeneic or stem cell derived therapeutic cells) which then release proteins and/or hormones as required.

Forward Looking Information

This release may contain forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although Sernova believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Forward-looking statements, which include our beliefs about the functionality of the Cell Pouch and our expectations of the potential benefits of listing on the OTCQB, are based on the beliefs, estimates and opinions of Sernova's management on the date such statements were made. Sernova expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information:

Sernova Corp.
Philip Toleikis, Ph.D.
President and CEO
(604) 961-2939 /

Ray Matthews & Associates
Suite 601-128 West Cordova Street, Vancouver, BC V6B 0E6
(604) 818-7778